Created in 2012 (United States), CORGLUTAL own 588 sister brands and 17477 competing brands. CORGLUTAL is owned by ELI LILLY AND COMPANY, listed on the stock exchange of New York The sector of CORGLUTAL is Drug Manufacturers.

CORGLUTAL is a brand of ELI LILLY AND COMPANY (LLY) Share price

Share price and profitability of the share ELI LILLY AND COMPANY (CORGLUTAL)

Buy ELI LILLY AND COMPANY share with

(0% commission and fractional shares)

Your capital is subject to risk. Other fees apply. For more information, visit etoro.com/trading/fees.

Investment simulator :

Amount invested USD 745.95

Portfolio valuation
ELI LILLY AND COMPANY (CORGLUTAL) over 5 years* USD 4,756.45

Stock market history ELI LILLY AND COMPANY (CORGLUTAL)

Market prices -> Notoriety

*non inclusive of dividends, non inclusive of market orders
past performances do not prejudice future performances

Other brands
ELI LILLY AND COMPANY

POINT BIOPHARMA

DICE Therapeutics

Pharmaserve-Lilly

See more brands of ELI LILLY AND COMPANY

Rival brands
CORGLUTAL

OTHER RIVAL BRANDS

Top Popularity Web

See the full ranking

Desirable brands > Pricing Power > 5 major sectors

Desirable brands > Pricing Power > 5 major sectors

Only companies with a strong brand or unique know-how benefit from this ability to set their prices without impacting demand and thus preserve their margins.

Read more